Antiviral activity of lauryl gallate against animal viruses

Antiviral Therapy

Volumn 13, Issue 7, 2008, Pages 909-917

  Hurtado, Carolina ^a   Bustos, Maria Jose ^a   Sabina, Prado ^a   Nogal, Maria Luisa ^a   Granja, Aitor G ^a,b   González, Maria Eugenia ^c   Gónzalez Porqué, Pedro ^d   Revilla, Yolanda ^a   Carrascosa, Angel L ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b THE FRANCIS CRICK INSTITUTE   (United Kingdom)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CELL DNA; DODECYL GALLATE; PROTEIN P53; VIRUS DNA; VIRUS PROTEIN; VIRUS RNA;

AFRICAN SWINE FEVER VIRUS; ANIMAL CELL; ANTIVIRAL ACTIVITY; APOPTOSIS; ARTICLE; CELL LEVEL; CELL VIABILITY; CONTROLLED STUDY; DNA SYNTHESIS; DRUG EFFICACY; ENZYME ACTIVATION; HERPES SIMPLEX VIRUS; HOST CELL; INFLUENZA VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN SYNTHESIS; SINDBIS VIRUS; TARGET CELL; TRANSMISSIBLE GASTROENTERITIS VIRUS; VACCINIA VIRUS; VERO CELL; VIROGENESIS; VIRUS TRANSCRIPTION; VIRUS VIRULENCE;

AFRICAN SWINE FEVER VIRUS; ANIMALS; ANTIVIRAL AGENTS; CELL LINE; CERCOPITHECUS AETHIOPS; CRICETINAE; DNA VIRUSES; DNA, VIRAL; GALLIC ACID; PROTEINS; RNA VIRUSES; VERO CELLS; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 56749096798     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. De Clercq E. Antivirals and antiviral strategies. Nat Rev Microbiol 2004; 2:704-720.
2. Schang LM. Cyclin-dependent kinases as cellular targets for antiviral drugs. J Antimicrob Chemother 2002; 50:779-792.
3. Fauci AS, Challberg MD. Host-based antipoxvirus therapeutic strategies: turning the tables. J Clin Invest 2005; 115:231-233.
4. Yang H, Kim SK, Kim M, et al. Antiviral chemotherapy facilitates control of poxvirus infections through inhibition of cellular signal transduction. J Clin Invest 2005; 115:379-387.
5. Serrano A, Palacios C, Roy G, et al. Derivatives of gallic acid induce apoptosis in tumoral cell lines and inhibit lymphocyte proliferation. Arch Biochem Biophys 1998; 350:49-54.
6. Abe I, Umehara K, Morita R, et al. Green tea polyphenols as potent enhancers of glucocorticoid-induced mouse mammary tumor virus gene expression. Biochem Biophys Res Commun 2001; 281:122-125.
7. Calcabrini A, Garcia-Martinez JM, Gonzalez L, et al. Inhibition of proliferation and induction of apoptosis in human breast cancer cells by lauryl gallate. Carcinogenesis 2006; 27:1699-1712.
8. Roy G, Lombardia M, Palacios P, et al. Mechanistic aspects of the induction of apoptosis by lauryl gallate in the murine B-cell lymphoma line Wehi 231. Arch Biochem Biophys 2000; 383:206-214.
9. Lazaro I, Palacios C, Gonzalez M, Gonzalez-Porque P. Inhibition of human spleen protein tyrosine kinases by phenolic compounds. Anal Biochem 1995; 225:180-183.
10. Palacios C, Cespon C, Martin de la Vega C, et al. Lauryl gallate inhibits the activity of protein tyrosine kinase c-Src purified from human platelets. J Enzyme Inhib 2001; 16:527-533.
11. Ortega E, Sadaba MC, Ortiz AI, et al. Tumoricidal activity of lauryl gallate towards chemically induced skin tumours in mice. Br J Cancer 2003; 88:940-943.
12. Kane CJ, Menna JH, Sung CC, Yeh YC. Methyl gallate, methyl-3,4,5-trihydoxybenzoate, is a potent and highly specific inhibitor of herpes simplex virus in vitro. II. Antiviral activity of methyl gallate and its derivatives. Biosci Rep 1988; 8:95-102.
13. Uozaki M, Yamasaki H, Katsuyama Y, Higuchi M, Higuti T, Koyama AH. Antiviral effect of octyl gallate against DNA and RNA viruses. Antiviral Res 2007; 73:85-91.
14. Yamasaki H, Uozaki M, Katsuyama Y, et al. Antiviral effect of octyl gallate against influenza and other RNA viruses. Int J Mol Med 2007; 19:685-688.
15. Carrascosa AL, Santaren JF, Vinuela E. Production and titration of African swine fever virus in porcine alveolar macrophages. J Virol Methods 1982; 3:303-310.
16. Enjuanes L, Carrascosa AL, Moreno MA, Vinuela E. Titration of African swine fever (ASF) virus. J Gen Virol 1976; 32:471-477.
17. Garcia-Barreno B, Sanz A, Nogal ML, Vinuela E, Enjuanes L. Monoclonal antibodies of African swine fever virus: antigenic differences among field virus isolates and viruses passaged in cell culture. J Virol 1986; 58:385-392.
18. Carrascosa AL, Sastre I, Vinuela E. Production and purification of recombinant African swine fever virus attachment protein p12. J Biotechnol 1995; 40:73-86.
19. Ortin J, Vinuela E. Requirement of cell nucleus for African swine fever virus replication in Vero cells. J Virol 1977; 21:902-905.
20. del Val M, Vinuela E. Glycosylated components induced in African swine fever (ASF) virus-infected Vero cells. Virus Res 1987; 7:297-308.
21. Carrascosa AL, Bustos MJ, Nogal ML, Gonzalez de Buitrago G, Revilla Y. Apoptosis induced in an early step of African swine fever virus entry into vero cells does not require virus replication. Virology 2002; 294:372-382.
22. Granja AG, Nogal ML, Hurtado C, et al. Modulation of p53 cellular function and cell death by African swine fever virus. J Virol 2004; 78:7165-7174.
23. Nogal ML, Gonzalez de Buitrago G, Rodriguez C, et al. African swine fever virus IAP homologue inhibits caspase activation and promotes cell survival in mammalian cells. J Virol 2001; 75:2535-2543.